Non classé

On 8 October 2026, the CCHFVACIM consortium gathered at the Makedonia Hotel in Thessaloniki, Greece, for its third annual meeting. With remote participation also available, the meeting brought partners together to review progress across the project, discuss scientific challenges and consider priorities for the coming months. The programme covered the complementary research approaches underpinning CCHFVACIM’s…

(…)

Watch our second video.

(…)

New CCHFVACIM-supported study sheds light on CCHFV infection dynamics in sheep A new study supported by the CCHFVACIM project provides detailed insights into how Crimean-Congo haemorrhagic fever virus (CCHFV) disseminates in sheep and how the animals’ immune response develops over time. Published in npj Viruses, the study was led by researchers from the Friedrich-Loeffler-Institut, with…

(…)

Watch our new video.

(…)

Advancing research and collaboration in CCHFV preparedness. CCHFVACIM is driving forward cutting-edge research through a collaborative, multidisciplinary approach to pandemic preparedness. During the first phase of the project, important scientific advances have been achieved, including the characterization of key viral structures and immune responses, as well as the identification of promising vaccine targets. The project…

(…)

CCHFVACIM Builds on EU Research to Advance a Vaccine Significant progress has been made in the global fight against Crimean-Congo Haemorrhagic Fever (CCHF) — a severe tick-borne viral disease with fatality rates that can reach 40 % and no licensed vaccine available. CCHF is transmitted to humans through the bite of infected Hyalomma ticks, and…

(…)

CCHFVACIM reaches key milestones in its first reporting period. The CCHFVACIM project has made significant progress during its first reporting period (January 2024 – June 2025), laying strong foundations for the development of innovative vaccines and immunotherapies against Crimean-Congo Haemorrhagic Fever (CCHF). Among the key achievements, the consortium successfully designed and evaluated multiple mRNA-based vaccine…

(…)

Our team developed a rapid, versatile “plug-and-play” pseudotyped virus neutralisation assay that allows scientists to measure immune responses to several dangerous bunyaviruses without needing high-containment (BSL-3/4) facilities.This is a major step forward because: 🔍 Why it matters for CCHFVACIMThe CCHFVACIM project aims to advance vaccines and medical countermeasures against CCHFV. One of our biggest bottlenecks…

(…)

Greek health authorities have reported a confirmed case of Crimean-Congo hemorrhagic fever (CCHF) in a 71-year-old man. Initially presenting with fever, myalgia, and gastrointestinal symptoms, his condition evolved rapidly to include neurological signs and hemorrhages, leading to his death shortly after diagnosis. 🇬🇷 This is Greece’s first CCHF case in 2025 and only the second…

(…)

CCHF Epidemic watch The Iraqi Ministry of Health has reported a growing number of cases and deaths linked to Crimean-Congo Hemorrhagic Fever (CCHF), signaling one of the country’s most significant outbreaks in recent years.As of late September 2025, 296 confirmed infections and 42 deaths have been recorded nationwide since the beginning of the year —…

(…)